Mark  Daniels net worth and biography

Mark Daniels Biography and Net Worth

Insider of Twist Bioscience
Mark Daniels J.D. serves as Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer and Secretary of the Company. Prior to joining us, from January 2013 to May 2016, Mr. Daniels was at Broadcom Corporation, a semiconductor manufacturer and producer of wireless and broadband products, where his most recent position was Vice President, Law and Deputy Chief Corporate Compliance Officer. Before that, he spent 20 years in positions of increasing responsibility in the legal department at Amgen, Inc., a producer of biopharmaceuticals, where his last role was Vice President and Associate General Counsel. Mr. Daniels received his B.S. with honors in Industrial and Labor Relations from Cornell University and a J.D., cum laude, from Harvard Law School.

What is Mark Daniels' net worth?

The estimated net worth of Mark Daniels is at least $2.28 million as of March 29th, 2021. Mr. Daniels owns 67,303 shares of Twist Bioscience stock worth more than $2,276,860 as of March 19th. This net worth approximation does not reflect any other investments that Mr. Daniels may own. Learn More about Mark Daniels' net worth.

How do I contact Mark Daniels?

The corporate mailing address for Mr. Daniels and other Twist Bioscience executives is 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA, 94080. Twist Bioscience can also be reached via phone at (800) 719-0671 and via email at [email protected]. Learn More on Mark Daniels' contact information.

Has Mark Daniels been buying or selling shares of Twist Bioscience?

Mark Daniels has not been actively trading shares of Twist Bioscience during the past quarter. Most recently, Mark Daniels sold 1,167 shares of the business's stock in a transaction on Wednesday, March 31st. The shares were sold at an average price of $112.28, for a transaction totalling $131,030.76. Learn More on Mark Daniels' trading history.

Who are Twist Bioscience's active insiders?

Twist Bioscience's insider roster includes William Banyai (Insider), Robert Chess (Director), Keith Crandell (Director), Mark Daniels (Insider), Patrick Finn (Insider), Paula Green (SVP), Jan Johannessen (Director), Emily Leproust (CEO), James Thorburn (CFO), and Patrick Weiss (COO). Learn More on Twist Bioscience's active insiders.

Are insiders buying or selling shares of Twist Bioscience?

In the last year, Twist Bioscience insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $132,000.00. In the last year, insiders at the sold shares 6 times. They sold a total of 6,743 shares worth more than $242,057.80. The most recent insider tranaction occured on March, 14th when insider Dennis Cho sold 93 shares worth more than $3,217.80. Insiders at Twist Bioscience own 3.9% of the company. Learn More about insider trades at Twist Bioscience.

Information on this page was last updated on 3/14/2024.

Mark Daniels Insider Trading History at Twist Bioscience

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/31/2021Sell1,167$112.28$131,030.76
3/29/2021Sell377$114.39$43,125.0367,303View SEC Filing Icon  
3/24/2021Sell620$132.50$82,150.0067,546View SEC Filing Icon  
2/24/2021Sell620$134.31$83,272.2067,546View SEC Filing Icon  
2/4/2021Sell668$191.52$127,935.3668,868View SEC Filing Icon  
1/28/2021Sell377$161.02$60,704.5468,577View SEC Filing Icon  
1/25/2021Sell905$193.00$174,665.0068,485View SEC Filing Icon  
12/28/2020Sell377$167.10$62,996.7069,407View SEC Filing Icon  
12/24/2020Sell620$167.79$104,029.8069,407View SEC Filing Icon  
8/17/2020Sell20,994$68.07$1,429,061.5874,712View SEC Filing Icon  
8/13/2020Sell14,502$64.53$935,814.0668,220View SEC Filing Icon  
6/10/2020Sell1,962$36.01$70,651.6253,718View SEC Filing Icon  
9/16/2019Sell1,500$29.90$44,850.00
See Full Table

Mark Daniels Buying and Selling Activity at Twist Bioscience

This chart shows Mark Daniels's buying and selling at Twist Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Twist Bioscience Company Overview

Twist Bioscience logo
Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $33.83
Low: $32.87
High: $34.52

50 Day Range

MA: $36.65
Low: $32.28
High: $41.50

2 Week Range

Now: $33.83
Low: $11.46
High: $43.21

Volume

634,175 shs

Average Volume

995,473 shs

Market Capitalization

$1.96 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.64